Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Kreos Capital
United Kingdom
- London
- 09/11/2022
- Series C
- $50,000,000
Kreos Capital is Europe's largest and leading provider of growth debt to high-growth companies with revenues up to €200 million. Since 1998, as the pioneer growth debt provider across the Europe and Israel, Kreos has completed over 740 transactions and committed over €4 billion in 18 different countries. Kreos has a proven track record of adding value to portfolio companies and helping them to grow with additional capital and flexibility throughout their business cycle whilst working closely with both the portfolio company management team and their equity sponsors.
The Kreos global team has extensive debt financing, management and equity investing experience, covering the pan-European market from its locations in London, Tel Aviv and Stockholm.
- Industry Financial Services
- Website https://www.kreoscapital.com/
- LinkedIn https://www.linkedin.com/company/kreos-capital/
Related People
Aris ConstantinidesInvestor
United States -
London, England,
Senior international executive with excellent investment/exit track record in investing, managing and exiting high growth businesses. Specialized in debt, growth equity, secondaries and venture capital investments in technology and lifescience high growth businesses.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)